Authors: Hasinoff, BB Abram, ME Barnabe, N Khelifa, T Allan, WP Yalowich, JC

Citation: Bb. Hasinoff et al., The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells, MOLEC PHARM, 59(3), 2001, pp. 453-461

Authors: Khelifa, T Beck, WT

Citation: T. Khelifa et Wt. Beck, Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease, MOLEC PHARM, 55(3), 1999, pp. 548-556

Authors: Khelifa, T Rene, B Le Mee, S Lambert, B Saucier, JM Markovits, J Jacquemin-Sablon, H Jacquemin-Sablon, A

Citation: T. Khelifa et al., Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblastswith human topoisomerase II alpha cDNA: Selective restoration of the sensitivity to DNA religation inhibitors, CANCER RES, 59(19), 1999, pp. 4927-4936

Authors: Khelifa, T Beck, WT

Citation: T. Khelifa et Wt. Beck, Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells, BIOCH PHARM, 58(8), 1999, pp. 1247-1257